Finance

Lists
Why is 000105 up 6,74%?
Dive Deeper
000105:KRX
Yuhan Corp Preference Shares
71 300,00 ₩
+6,74%
(+4 500,00) 1D
19 հոկ, 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 000105...
Open
66 800 ₩
High
71 700 ₩
Low
66 100 ₩
Mkt. cap
6,52 տրլն
Avg. vol.
574,00
Volume
5,17 հզր
Dividend
0,84%
Quarterly dividend
150 ₩
Ex-dividend date
26 փտվ, 2026 թ.
P/E ratio
22,41
52-wk high
115 300 ₩
52-wk low
55 100 ₩
EPS
3 181 ₩
Shares outstanding
1,15 մլն
No. of employees
2 հզր
Open
66 800 ₩
High
71 700 ₩
Low
66 100 ₩
Mkt. cap
6,52 տրլն
Avg. vol.
574,00
Volume
5,17 հզր
Dividend
0,84%
Quarterly dividend
150 ₩
Ex-dividend date
26 փտվ, 2026 թ.
P/E ratio
22,41
52-wk high
115 300 ₩
52-wk low
55 100 ₩
EPS
3 181 ₩
Shares outstanding
1,15 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
9 ժամ առաջ
IBK cuts target for Yuhan stock to KRW 110,000
Profile
Yuhan Corporation is a South Korean pharmaceutical and chemical company headquartered in Daebang-dong, Dongjak-gu, Seoul. It was established in 1926 by New Il-han and has been listed on the Korea Stock Exchange since 1962. Yuhan is one of the top Korean pharmaceutical companies, along with Celltrion, Samsung Biologics, GC Pharma, and Hanmi Pharmaceutical. Wikipedia
About Yuhan Corp Preference Shares
CEOWook Je Cho
Employees2,08 հզր
Founded1926
Headquarters-
Sector-
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
570,01 մլրդ
546,07 մլրդ
526,78 մլրդ
639,45 մլրդ
Cost of goods sold
401,57 մլրդ
333,27 մլրդ
377,63 մլրդ
411,75 մլրդ
Cost of revenue
401,57 մլրդ
333,27 մլրդ
377,63 մլրդ
411,75 մլրդ
Research and development expenses
45,94 մլրդ
78,04 մլրդ
47,24 մլրդ
60,12 մլրդ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
94,69 մլրդ
103,16 մլրդ
88,43 մլրդ
99,40 մլրդ
Operating expense
146,43 մլրդ
185,79 մլրդ
140,37 մլրդ
160,70 մլրդ
Total operating expenses
548,00 մլրդ
519,05 մլրդ
518,00 մլրդ
572,45 մլրդ
Operating income
22,01 մլրդ
27,02 մլրդ
8,78 մլրդ
67,00 մլրդ
Other non operating income
-2,09 մլրդ
-4,58 մլրդ
231,25 մլն
-6,59 մլրդ
EBT including unusual items
35,18 մլրդ
120,91 մլրդ
28,76 մլրդ
88,37 մլրդ
EBT excluding unusual items
34,24 մլրդ
112,36 մլրդ
26,45 մլրդ
84,89 մլրդ
Income tax expense
14,01 մլրդ
10,77 մլրդ
5,39 մլրդ
20,33 մլրդ
Effective tax rate
39,83%
8,91%
18,75%
23,00%
Other operating expenses
1,68 մլրդ
3,00 մլրդ
1,94 մլրդ
2,87 մլրդ
Net income
25,28 մլրդ
114,43 մլրդ
27,04 մլրդ
70,32 մլրդ
Net profit margin
4,44%
20,96%
5,13%
11,00%
Earnings per share
348,00
1,53 հզր
372,00
950,00
Interest and investment income
2,11 մլրդ
2,13 մլրդ
2,35 մլրդ
2,47 մլրդ
Interest expense
-3,99 մլրդ
-3,91 մլրդ
-3,86 մլրդ
-3,89 մլրդ
Net interest expenses
-1,88 մլրդ
-1,77 մլրդ
-1,51 մլրդ
-1,42 մլրդ
Depreciation and amortization charges
2,12 մլրդ
962,24 մլն
1,52 մլրդ
1,48 մլրդ
EBITDA
40,00 մլրդ
44,17 մլրդ
27,88 մլրդ
90,47 մլրդ
Gain or loss from assets sale
9,44 մլն
-9,65 մլրդ
15,64 մլն
291,06 մլն
AI content may include mistakes. Learn more
Google Apps